Ahmed Mahiuddin 4
4 · Y-mAbs Therapeutics, Inc. · Filed May 27, 2020
Insider Transaction Report
Form 4
Ahmed Mahiuddin
Sr. VP & Chief Scientific Off
Transactions
- Sale
Common Stock
2020-05-26$39.38/sh−50,000$1,969,235→ 150,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $39.000 to $39.8700. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.